Ernexa Therapeutics Inc. (ERNA) Accumulated Depreciation (2015 - 2025)
Ernexa Therapeutics' (ERNA) quarterly Accumulated Depreciation came in at $197000.0 in Q4 2025, up 14.53% YoY from $172000.0 in Q4 2024, and up 14.53% on a QoQ basis from $172000.0 in Q4 2024.
Ernexa Therapeutics Inc. (ERNA) Accumulated Depreciation (2015 - 2025) Analysis & Trends
Ernexa Therapeutics (ERNA) has 11 years of Accumulated Depreciation data on file, last reported at $197000.0 in Q4 2025.
- Quarterly Accumulated Depreciation rose 14.53% year-over-year to $197000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $197000.0 (up 14.53% YoY) and the FY2025 annual result came in at $197000.0, up 14.53% from the prior year.
- Accumulated Depreciation improved to $197000.0 in Q4 2025, from $172000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $207000.0 in Q4 2021 to a low of $32000.0 in Q4 2022.
- A 5-year average of $144566.7 and a median of $158700.0 in 2021 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2022 — Accumulated Depreciation plunged 84.54% — and 2023, when it jumped 256.25%.
- Tracing ERNA's Accumulated Depreciation over 5 years: stood at $207000.0 in 2021, then sank by 84.54% to $32000.0 in 2022, then jumped by 256.25% to $114000.0 in 2023, then soared by 50.88% to $172000.0 in 2024, then rose by 14.53% to $197000.0 in 2025.
- The last three Accumulated Depreciation figures came in at $197000.0 (Q4 2025), $172000.0 (Q4 2024), and $114000.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 197,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 207,000.00 |
| Mar 31, 2021 | 145,400.00 |
| Dec 31, 2020 | 120,000.00 |
| Dec 31, 2019 | 9.17 Mn |
| Dec 31, 2018 | 10.50 Mn |
| Dec 31, 2017 | 10.32 Mn |
| Dec 31, 2016 | 10.99 Mn |
| Dec 31, 2015 | 12.46 Mn |